Follow The Filings

INSP Inspire Medical Systems Inc.

Health Care, filed as INSPIRE MED SYS INC (COM), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab

Sold by 1 manager in 2026 Q2

  • 2 Owners
  • Max 0.2%
  • $1.2M
  • 1 exit

In 2026 Q2 Ron Baron sold out of Inspire Medical Systems.

Who owns this now

Largest portfolio weights among holders, up to 0.2% (Nathan Fischel, Dafna Capital Management). Not free-float ownership.

  1. Nathan Fischel 0.15%
  2. Palo Alto Investors 0.05%

Who owns INSP

Sorted by value, long equity only, as of 2026 Q2.

History
Nathan Fischel, Dafna Capital Management 0.15% Hold 18,200 $812K History
Palo Alto Investors 0.05% Hold 8,772 $391K History
Ron Baron, Bamco Inc. (Baron Capital) exited 2026 Q2 Last 2026 Q1 0.05% Exit −0.05% 298,470 $15M History

Weight bar: held both quarters added sold at this quarter’s reported price

Insider trades

Open-market buys and sales by INSP's executives, directors and 10% owners in the last 12 months, from their Form 4s

All INSP insider trades
  • None no insider bought on the open market
  • $202K sold by 2 insiders outside a trading plan
  • $464K sold by 2 insiders under 10b5-1 plans
  1. Jason P Kelly See Remarks
    Sale
    $57K 963 shares at $59.55 4.8% of stake
    Traded Aug 7 Filed Aug 11
  2. John Rondoni See Remarks
    Sale
    $114K 2,641 shares at $43.28 8.9% of stake
    Traded May 15 Filed May 19
  3. John Rondoni See Remarks
    Sale
    $30K 700 shares at $43.01 2.3% of stake
    Traded May 14 Filed May 15
  4. Shawn mcCormick Director
    Planned sale
    $32K 696 shares at $45.31 2.5% of stake
    Traded May 8 Filed May 11
  5. John Rondoni See Remarks
    Planned sale
    $11K 109 shares at $100.00 0.8% of stake
    Traded Jan 9 Filed Jan 12
  6. Shawn mcCormick Director
    Planned sale
    $167K 1,200 shares at $139.00 4.6% of stake
    Traded Dec 2, 2025 Filed Dec 4, 2025
  7. Shawn mcCormick Director
    Planned sale
    $255K 2,000 shares at $127.48 7.1% of stake
    Traded Nov 28, 2025 Filed Dec 1, 2025
  8. Myriam Curet Director
    Buy
    $804 5 shares at $160.72 +0.1% to stake
    Traded Mar 20, 2025–Apr 7, 2025 Filed Nov 24, 2025
  9. Myriam Curet Director
    Sale
    $616 6 shares at $102.59 0.2% of stake
    Traded May 8, 2025–Aug 8, 2025 Filed Nov 24, 2025

Also filed in the last 12 months, not counted as buying or selling: 38 stock grants and 18 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
SCHEDULE 13G/A —
SCHEDULE 13G —
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.02
8-K 5.02,9.01
SCHEDULE 13G —
8-K 7.01,9.01
SCHEDULE 13G —
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 5.02,5.03,5.07,9.01
8-K 2.02,7.01,9.01
10-Q
SCHEDULE 13G —

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $624.8M $802.8M $911.98M
Gross profit $528.22M $679.82M $778.76M
Gross margin * 84.5% 84.7% 85.4%
Net income -$21.15M $53.51M $145.42M
Net margin * -3.4% 6.7% 15.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $593.74M $630.81M $583.65M
Total non-current assets * $83.07M $177.58M $323.66M
Total assets $676.81M $808.38M $907.32M
Total current liabilities $78.1M $88.5M $96.06M
Total non-current liabilities * $26.19M $30.19M $30.1M
Total equity $572.51M $689.7M $781.16M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $24.65M $130.25M $116.98M
Cash from investing -$294.82M -$113.12M $21.45M
Cash from financing $13.95M -$52.39M -$183.45M
Net change in cash -$256.06M -$35.39M -$45.34M

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.